These findings are in line with recent reports showing that depletion of ACTN1 (Chen et al, 2021; Xie et al, 2020) inhibited the growth of hepatocellular carcinoma and oral squamous cell carcinoma, however it has not yet been explored for improving sensitivity to NAC in TNBC. Here, ACTN1 is linked to oral cavity squamous cell carcinoma.